Show simple item record

dc.contributor.authorPicardo, M
dc.contributor.authorSchor, Seth L
dc.contributor.authorGrey, A M
dc.contributor.authorHowell, Anthony
dc.contributor.authorLaidlaw, Ian
dc.contributor.authorRedford, Judy
dc.contributor.authorSchor, Ana M
dc.date.accessioned2010-06-10T08:29:47Z
dc.date.available2010-06-10T08:29:47Z
dc.date.issued1991-01-19
dc.identifier.citationMigration stimulating activity in serum of breast cancer patients. 1991, 337 (8734):130-3 Lanceten
dc.identifier.issn0140-6736
dc.identifier.pmid1670786
dc.identifier.doi10.1016/0140-6736(91)90798-T
dc.identifier.urihttp://hdl.handle.net/10541/104594
dc.description.abstractAn assay to measure the ability to stimulate migration of fibroblasts into collagen gel was carried out on serum from treated and untreated breast cancer patients and from healthy controls. Migration stimulating activity was found in the serum of 10 (83%) of 12 untreated breast cancer patients immediately before surgical resection of the primary tumour and in 9 (75%) of them 4 days after resection; in 13 (93%) of 14 patients 1-13 years after tumour resection who had received adjuvant treatment; and in 2 (10%) of 20 healthy women matched for age. The migration stimulating activity in cancer patients' serum was indistinguishable from the migration stimulating factor produced in vitro by fetal and cancer patient skin fibroblasts in its behaviour in various biochemical fractionation procedures. The presence of this activity in the serum of treated breast cancer patients clearly distinguishes it from other oncofetal proteins, which all seem to be produced by tumours.
dc.language.isoenen
dc.subjectBreast Canceren
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBreast Neoplasms
dc.subject.meshCell Movement
dc.subject.meshCytokines
dc.subject.meshFemale
dc.subject.meshFibroblasts
dc.subject.meshHumans
dc.subject.meshMiddle Aged
dc.subject.meshPredictive Value of Tests
dc.titleMigration stimulating activity in serum of breast cancer patients.en
dc.typeArticleen
dc.contributor.departmentDepartment of Cell and Structural Biology, University of Manchester, UK.en
dc.identifier.journalLanceten
html.description.abstractAn assay to measure the ability to stimulate migration of fibroblasts into collagen gel was carried out on serum from treated and untreated breast cancer patients and from healthy controls. Migration stimulating activity was found in the serum of 10 (83%) of 12 untreated breast cancer patients immediately before surgical resection of the primary tumour and in 9 (75%) of them 4 days after resection; in 13 (93%) of 14 patients 1-13 years after tumour resection who had received adjuvant treatment; and in 2 (10%) of 20 healthy women matched for age. The migration stimulating activity in cancer patients' serum was indistinguishable from the migration stimulating factor produced in vitro by fetal and cancer patient skin fibroblasts in its behaviour in various biochemical fractionation procedures. The presence of this activity in the serum of treated breast cancer patients clearly distinguishes it from other oncofetal proteins, which all seem to be produced by tumours.


Files in this item

This item appears in the following Collection(s)

Show simple item record